1. Home
  2. SA vs HAE Comparison

SA vs HAE Comparison

Compare SA & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Seabridge Gold Inc. (Canada)

SA

Seabridge Gold Inc. (Canada)

HOLD

Current Price

$34.01

Market Cap

3.7B

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$57.76

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SA
HAE
Founded
1979
1971
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Medical/Dental Instruments
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7B
3.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
SA
HAE
Price
$34.01
$57.76
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$65.00
$86.00
AVG Volume (30 Days)
1.4M
1.1M
Earning Date
03-26-2026
02-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
43.84
EPS
N/A
3.65
Revenue
N/A
$1,318,275,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$5.86
P/E Ratio
N/A
$15.82
Revenue Growth
N/A
N/A
52 Week Low
$9.40
$47.32
52 Week High
$37.99
$87.32

Technical Indicators

Market Signals
Indicator
SA
HAE
Relative Strength Index (RSI) 52.04 23.44
Support Level $31.68 $55.95
Resistance Level $34.70 $60.50
Average True Range (ATR) 2.15 2.35
MACD 0.04 -0.58
Stochastic Oscillator 57.61 15.70

Price Performance

Historical Comparison
SA
HAE

About SA Seabridge Gold Inc. (Canada)

Seabridge Gold Inc is a development stage company involved in the exploration, and development of gold properties sited in North America. The company's principal projects include the Kerr-Sulphurets-Mitchell property located in British Columbia, the Courageous Lake property located in the Northwest Territories, and Iksut Property located in northwestern British Columbia, and the 3 Aces Project in southeast Yukon. The company has various other mineral resource projects throughout North America.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: